
| Changed: | ||||||||
| < < |
| |||||||
| > > |
| |||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (X71)ProtocolAbout the protein: see the Protein acquisition form. conditions to screen:
Comments (June 2nd meeting)Later, ligands will be used (TPP+ in the buffer: 20 uM or 100 uM as substrate for the protein, at pH=8 only)
| ||||||||
2dx - EmrE 2D-crystallization trials | ||||||||
| Changed: | ||||||||
| < < | Experiment of Mai 2011 (EM.174 - X67) | |||||||
| > > | Experiment of Mai 2011 (X71) | |||||||
ProtocolAbout the protein: see the Protein acquisition form. conditions to screen:
| ||||||||
| Added: | ||||||||
| > > | Set 2nd June. Stopped 14th June. | |||||||
Comments (June 2nd meeting)Later, ligands will be used (TPP+ in the buffer: 20 uM or 100 uM as substrate for the protein, at pH=8 only)
| ||||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (EM.174 - X67)Protocol | ||||||||
| Added: | ||||||||
| > > | About the protein: see the Protein acquisition form. | |||||||
conditions to screen:
Comments (June 2nd meeting)Later, ligands will be used (TPP+ in the buffer: 20 uM or 100 uM as substrate for the protein, at pH=8 only)
| ||||||||
| Deleted: | ||||||||
| < < | * Nanda_EmrE_D5-Protein_acquisition_form.doc: Nanda_EmrE_D5-Protein_acquisition_form.doc | |||||||
| Changed: | ||||||||
| < < |
| |||||||
| > > |
| |||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (EM.174 - X67)Protocolconditions to screen:
Comments (June 2nd meeting)Later, ligands will be used (TPP+ in the buffer: 20 uM or 100 uM as substrate for the protein, at pH=8 only)
| ||||||||
| Added: | ||||||||
| > > | * Nanda_EmrE_D5-Protein_acquisition_form.doc: Nanda_EmrE_D5-Protein_acquisition_form.doc | |||||||
| ||||||||
| Added: | ||||||||
| > > |
| |||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (EM.174 - X67)Protocolconditions to screen: | ||||||||
| Changed: | ||||||||
| < < |
| |||||||
| > > |
| |||||||
Comments (June 2nd meeting)Later, ligands will be used (TPP+ in the buffer: 20 uM or 100 uM as substrate for the protein, at pH=8 only)
| ||||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (EM.174 - X67)Protocolconditions to screen: | ||||||||
| Changed: | ||||||||
| < < | ||||||||
| > > |
| |||||||
| ||||||||
| Changed: | ||||||||
| < < |
| |||||||
| > > |
| |||||||
See Protocol_EmrE_2011_Mai.xls for details.
Comments (June 2nd meeting)Later, ligands will be used (TPP+ in the buffer: 20 uM or 100 uM as substrate for the protein, at pH=8 only)
| ||||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (EM.174 - X67)Protocolconditions to screen:
Comments (June 2nd meeting)Later, ligands will be used (TPP+ in the buffer: 20 uM or 100 uM as substrate for the protein, at pH=8 only)
| ||||||||
| Changed: | ||||||||
| < < |
| |||||||
| > > |
| |||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (EM.174 - X67)Protocolconditions to screen:
Comments (June 2nd meeting)Later, ligands will be used (TPP+ in the buffer: 20 uM or 100 uM as substrate for the protein, at pH=8 only)
| ||||||||
| Changed: | ||||||||
| < < |
| |||||||
| > > |
| |||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (EM.174 - X67)Protocolconditions to screen:
Comments (June 2nd meeting)Later, ligands will be used (TPP+ in the buffer: 20 uM or 100 uM as substrate for the protein, at pH=8 only)
| ||||||||
| Changed: | ||||||||
| < < |
| |||||||
| > > |
| |||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (EM.174 - X67)Protocolconditions to screen: | ||||||||
| Changed: | ||||||||
| < < |
| |||||||
| > > | ||||||||
| ||||||||
| Changed: | ||||||||
| < < |
| |||||||
| > > |
| |||||||
| Added: | ||||||||
| > > |
| |||||||
| ||||||||
| Added: | ||||||||
| > > |
| |||||||
| Deleted: | ||||||||
| < < | Do it in the dialysis block and a few in biobeads at 4 degrees for an overnight test. Then, use it also to test the sucrose gradient method. | |||||||
| See Protocol_EmrE_2011_Mai.xls for details. | ||||||||
| Added: | ||||||||
| > > | Comments (June 2nd meeting)Later, ligands will be used (TPP+ in the buffer: 20 uM or 100 uM as substrate for the protein, at pH=8 only) | |||||||
| Added: | ||||||||
| > > | ||||||||
| ||||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (EM.174 - X67)Protocolconditions to screen:
| ||||||||
| Changed: | ||||||||
| < < |
| |||||||
| > > |
| |||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (EM.174 - X67)Protocolconditions to screen: | ||||||||
| Changed: | ||||||||
| < < |
| |||||||
| > > |
| |||||||
| ||||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (EM.174 - X67)Protocolconditions to screen:
| ||||||||
| Changed: | ||||||||
| < < |
| |||||||
| > > |
| |||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (EM.174 - X67)Protocolconditions to screen:
| ||||||||
| Added: | ||||||||
| > > | See Protocol_EmrE_2011_Mai.xls for details. | |||||||
| Deleted: | ||||||||
| < < | ||||||||
| ||||||||
| Changed: | ||||||||
| < < | * Protocol_EmrE_2011_Mai.xls: Protocol_EmrE_2011_Mai.xls | |||||||
| > > | ||||||||
| ||||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (EM.174 - X67)Protocolconditions to screen:
| ||||||||
| Added: | ||||||||
| > > | * Protocol_EmrE_2011_Mai.xls: Protocol_EmrE_2011_Mai.xls
| |||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (EM.174 - X67)Protocolconditions to screen:
| ||||||||
| Changed: | ||||||||
| < < |
| |||||||
| > > |
| |||||||
| ||||||||
2dx - EmrE 2D-crystallization trialsExperiment of Mai 2011 (EM.174 - X67)Protocolconditions to screen:
|